mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-05 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |